Literature DB >> 31735603

Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors.

Saswati Chatterjee1.   

Abstract

Mesh：

Year:  2019        PMID： 31735603      PMCID： PMC6904667          DOI： 10.1016/j.ymthe.2019.11.002

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  17 in total

1.  Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction.

Authors:  G Fisher-Adams; K K Wong; G Podsakoff; S J Forman; S Chatterjee
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

Review 2.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

3.  Gene targeting in vivo by adeno-associated virus vectors.

Authors:  Daniel G Miller; Pei-Rong Wang; Lisa M Petek; Roli K Hirata; Mark S Sands; David W Russell
Journal:  Nat Biotechnol       Date:  2006-07-30       Impact factor: 54.908

4.  When Silent Mutations Provide Evolutionary Advantages.

Authors:  Joseph Caspermeyer
Journal:  Mol Biol Evol       Date:  2016-05-02       Impact factor: 16.240

5.  AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCs.

Authors:  Amanda M Dudek; Matthew H Porteus
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

6.  A capillary electrophoresis sequencing method for the identification of mutations in the inverted terminal repeats of adeno-associated virus.

Authors:  Cameron Mroske; Hector Rivera; Taihra Ul-Hasan; Saswati Chatterjee; K K Wong
Journal:  Hum Gene Ther Methods       Date:  2012-05-21       Impact factor: 2.396

7.  Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.

Authors:  Liujiang Song; M Ariel Kauss; Etana Kopin; Manasa Chandra; Taihra Ul-Hasan; Erin Miller; Giridhara R Jayandharan; Angela E Rivers; George V Aslanidi; Chen Ling; Baozheng Li; Wenqin Ma; Xiaomiao Li; Lourdes M Andino; Li Zhong; Alice F Tarantal; Mervin C Yoder; Kamehameha K Wong; Mengqun Tan; Saswati Chatterjee; Arun Srivastava
Journal:  Cytotherapy       Date:  2013-08       Impact factor: 5.414

8.  Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break.

Authors:  Geoffrey L Rogers; Hsu-Yu Chen; Heidy Morales; Paula M Cannon
Journal:  Mol Ther       Date:  2019-09-09       Impact factor: 11.454

9.  H2AX is required for cell cycle arrest via the p53/p21 pathway.

Authors:  Michalis Fragkos; Jaana Jurvansuu; Peter Beard
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

10.  Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing.

Authors:  Laura J Smith; Jason Wright; Gabriella Clark; Taihra Ul-Hasan; Xiangyang Jin; Abigail Fong; Manasa Chandra; Thia St Martin; Hillard Rubin; David Knowlton; Jeff L Ellsworth; Yuman Fong; Kamehameha K Wong; Saswati Chatterjee
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-17       Impact factor: 11.205
View more
  3 in total

1.  Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic Medicines.

Authors:  Saswati Chatterjee; Venkatesh Sivanandam; Kamehameha Kai-Min Wong
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

Review 2.  Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.

Authors:  Byung-Chul Lee; Richard J Lozano; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2021-09-10       Impact factor: 11.454

3.  Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing.

Authors:  Hua Yang; Keyun Qing; Geoffrey D Keeler; Ling Yin; Mario Mietzsch; Chen Ling; Brad E Hoffman; Mavis Agbandje-McKenna; Mengqun Tan; Wei Wang; Arun Srivastava
Journal:  Mol Ther Nucleic Acids       Date:  2020-03-29       Impact factor: 8.886
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.